Emergency Department Orders for Suspected Vasculitis
For patients with suspected vasculitis in the ED, immediately order ANCA testing (both PR3-ANCA and MPO-ANCA using antigen-specific assays), complete blood count, comprehensive metabolic panel, urinalysis with microscopy, inflammatory markers (ESR/CRP), and chest X-ray, while simultaneously obtaining tissue biopsy from the most accessible affected organ to confirm diagnosis. 1, 2
Immediate Laboratory Testing
Essential Serologic Studies
- ANCA testing is the cornerstone diagnostic test - order both PR3-ANCA and MPO-ANCA using high-quality antigen-specific assays as the primary testing method 1
- Complete blood count with differential (assess for anemia, thrombocytopenia, eosinophilia)
- Comprehensive metabolic panel including creatinine (critical threshold: >300 µmol/L indicates severe renal involvement) 1
- Inflammatory markers: ESR and CRP
- Urinalysis with microscopy looking for red blood cell casts, proteinuria, and hematuria (indicates glomerulonephritis)
Additional Laboratory Work
- Hepatitis B and C serologies (rule out secondary causes)
- HIV testing
- Complement levels (C3, C4)
- Antinuclear antibodies (ANA)
- Cryoglobulins if clinically indicated
- Blood cultures if febrile (infection can mimic vasculitis) 3
Immediate Imaging Studies
First-Line Imaging
- Chest X-ray - evaluate for pulmonary nodules, infiltrates, or hemorrhage
- CT chest without and with contrast if pulmonary involvement suspected (alveolar hemorrhage, cavitating nodules)
- Renal ultrasound if acute kidney injury present
Additional Imaging Based on Clinical Presentation
The 2022 research demonstrates that ultrasound and MRI are superior to PET/CT for detecting vascular changes 4:
- Ultrasound can identify vascular occlusion and halo sign (vessel wall thickening)
- MRI shows vessel wall thickening, edema, and diameter changes
- CT angiography for suspected mesenteric or cardiac involvement 5
Tissue Biopsy - Critical for Diagnosis
A positive biopsy is strongly supportive and should be obtained to establish new diagnosis 1. Target the most accessible affected organ:
- Kidney biopsy for suspected glomerulonephritis (most definitive)
- Skin biopsy if purpura or ulcerations present
- Nasal/sinus biopsy for upper respiratory tract involvement
- Lung biopsy (transbronchial or open) for isolated pulmonary disease
Organ-Specific Assessment
Life-Threatening Manifestations Requiring Immediate Evaluation 1, 2:
- Renal: Serum creatinine, urinalysis, consider nephrology consultation if creatinine >300 µmol/L
- Pulmonary: Arterial blood gas if respiratory distress, bronchoscopy if alveolar hemorrhage suspected
- Neurologic: CT/MRI brain for CNS involvement, nerve conduction studies for mononeuritis multiplex
- Cardiac: ECG, troponin, echocardiogram if cardiac symptoms
- Gastrointestinal: CT abdomen/pelvis with contrast for mesenteric ischemia
Non-Life-Threatening Manifestations 1:
- ENT examination for nasal/sinus disease
- Ophthalmology consultation for eye involvement (distinguish episcleritis from scleritis)
Critical Pitfalls to Avoid
- Do not delay ANCA testing - this is the primary diagnostic method, not immunofluorescence patterns 1
- Do not miss infection as a mimic - mycoplasma and other infections can cause vasculitis-like presentations 3
- Do not overlook drug-induced vasculitis - obtain detailed medication history including topical NSAIDs 3
- Do not discharge patients with suspected severe disease - glomerulonephritis, pulmonary hemorrhage, CNS involvement, mononeuritis multiplex, cardiac involvement, and mesenteric ischemia are organ-threatening 1, 2
Consultation and Disposition
- Immediate rheumatology consultation for all suspected cases - vasculitis requires multidisciplinary management by centers with expertise 1
- Nephrology consultation if renal involvement (creatinine elevation, abnormal urinalysis)
- Pulmonology consultation if pulmonary hemorrhage or significant respiratory involvement
- Admission required for any organ-threatening manifestations or inability to complete outpatient workup safely
Treatment Considerations in the ED
While definitive treatment decisions should involve rheumatology, be prepared to discuss:
- High-dose glucocorticoids (methylprednisolone 500-1000 mg IV daily for 3-5 days or prednisone 1 mg/kg/day) may be initiated for severe, organ-threatening disease after consultation 2
- Plasma exchange may be considered if creatinine >300 µmol/L due to active glomerulonephritis 1
- Definitive immunosuppression (rituximab or cyclophosphamide) should be coordinated with rheumatology 1, 2
The key distinction is identifying severe/organ-threatening disease (glomerulonephritis, pulmonary hemorrhage, CNS involvement, mononeuritis multiplex, cardiac/mesenteric involvement) versus non-severe disease (rhinosinusitis, non-ulcerating skin lesions, non-cavitating nodules, episcleritis), as this determines urgency of treatment initiation 1, 2.